| Literature DB >> 34285452 |
Abstract
This research explored the role of air travel in the spread of infectious diseases, specifically severe acute respiratory syndrome (SARS), H1N1, Ebola, and pneumonic plague. Air travel provides the means for such diseases to spread internationally at extraordinary rates because infected passengers jump from coast to coast and continent to continent within hours. Outbreaks of diseases that spread from person to person test the effectiveness of current public health responses. This research used a mixed methods approach, including use of the Spatiotemporal Epidemiological Modeler, to model the spread of diseases, evaluate the impact of air travel on disease spread, and analyze the effectiveness of different public health strategies and travel policies. Modeling showed that the spread of Ebola and pneumonic plague is minimal and should not be a major air travel concern if an individual becomes infected. H1N1 and SARS have higher infection rates and air travel will facilitate the spread of disease nationally and internationally. To contain the spread of infectious diseases, aviation and public health authorities should establish tailored preventive measures at airports, capture contact information for ticketed passengers, expand the definition of "close contact," and conduct widespread educational programs. The measures will put in place a foundation for containing the spread of infectious diseases via air travel and minimize the panic and economic consequences that may occur during an outbreak. © National Academy of Sciences: Transportation Research Board 2018.Entities:
Year: 2018 PMID: 34285452 PMCID: PMC8282645 DOI: 10.1177/0361198118799709
Source DB: PubMed Journal: Transp Res Rec ISSN: 0361-1981 Impact factor: 1.560
Figure 1.Global air travel routes.
Biological Characteristics of Disease of Interest
| SARS | H1N1 | Ebola | Pneumonic plague | |
|---|---|---|---|---|
| Family | Coronavirus (virus) | Orthomyxoviridae | Filoviridae | Enterobacteriaceae |
| Year of outbreak | 2003 | 2009 | 2014 | Hypothetical |
| Method of transmission | Person to person by air (e.g., coughing) and fecal–oral transmission (e.g., putting dirty hands near mouth) | Person to person by air (e.g., coughing) | Direct person-to-person contact through bodily fluids (e.g., sex) | Person to person by air (e.g., coughing) |
| Asymptomatic transmission possible? | Low possibility | Yes | No | No |
| Reproductive ratio (average # of new cases generated by each case) – Ro | 2–3 | 1.4–3.5 | 1.5–2.0 | 1.3 |
| Case fatality rate | 13% <60 yrs | 0.01%–0.3% | 50%–90% | 50% (if untreated, 99%) |
| Symptoms | Fever, general flu-like symptoms, muscle pain | Sudden fever, body aches (joints and throat), coughing, sneezing, extreme chills, fatigue, nasal congestion | Severe frontal and temporal headache, aches and pains, fever progressing to watery diarrhea, abdominal pain, nausea, vomiting | Sudden headaches, chills, malaise, and increased respiratory and heart rates progressing to cough and fever |
| Treatment or vaccine | Oseltamivir, supportive care, experimental vaccine | Oseltamivir, flu shot | Supportive care, experimental vaccines | Antibiotics effective if within 24 hours of symptoms |
| Incubation period | 1–14 days | 2–6 days | 2–21 days | 2–4 days |
| Duration of illness | 2–4 weeks | 1–2 weeks | 10–20 days | Death if untreated in 1–3 days |
Figure 2.SEIR compartment model.
Simulated and Actual Disease Cases
| Simulated and actual cases in the United States | ||
|---|---|---|
| Simulated diseases | Total infected | Total deaths |
| SARS – 1 | 4,042 | 572 |
| SARS – 10 | 7,279 | 1,000 |
| H1N1 – 1 | 5,617,702 | 5,374 |
| H1N1 – 10 | 18,363,550 | 18,856 |
| Ebola – 1 | 5 | 1 |
| Ebola – 10 | 43 | 19 |
| pneumonic plague – 1 | 1 | 1 |
| pneumonic plague – 10 | 25 | 13 |
| Historical diseases | Total infected | Total deaths |
| 2003 SARS | 27 | 0 |
| 2003 SARS | 438 | 44 |
| 2003 SARS | 5,327 | 349 |
| 2009 H1N1 | ~22 million | ~3,900 |
| 2014 Ebola | 4 | 1 |
| 2015 pneumonic plague | 11 | 3 |
Example of Disease Notice on Air Travel Ticket Purchases
| Notification of disease in travel areas, airports, or on airplanes |
|---|
| Do you wish to be notified of an outbreak of any infectious
disease of concern* reported in the travel area, airport, or
on board the airplane? |
| If yes, contact information must be provided: |
| □ Text: |
| □ E-mail: |
| □ Voicemail: |
| □ Other, please provide complete contact information: |
| All current travel alerts may be found at: |
| *Infectious diseases of concern include: (1) cholera, (2) diphtheria, (3) infectious tuberculosis, (4) plague, (5) smallpox, (6) yellow fever, (7), viral hemorrhagic fevers, (8) SARS, and (9) flu that can cause a pandemic. |
| Please consult the CDC website to determine if an outbreak is relevant to your travels. |
Example of a Health Notice Given during Air Travel Ticket Purchase
| WARNING: TRAVEL AREA HAS HEALTH ALERT FOR PNEUMONIC PLAGUE! |
|---|
| All current disease travel alerts and advisory notices may
be found at: |
| Do not travel if suspected of carrying a disease of concern.* |
| *Infectious diseases of concern include: (1) cholera, (2) diphtheria, (3) infectious tuberculosis, (4) plague, (5) smallpox, 6) yellow fever, (7), viral hemorrhagic fevers, (8) SARS, and 9) flu that can cause a pandemic. |
| Please consult the CDC website to determine if an outbreak is relevant to your travels. |
Example of a Thermal Screening Alert on an Air Travel Ticket
| **ALERT** |
|---|
| Your travel plans involve an airplane flying from New York City. |
| You may be subjected to random thermal screening due to a
suspected outbreak of SARS. If you suspect you are ill, do
not travel and delay your travel until fever symptoms have
subsided. Please consult a doctor if you have concerns about
disease exposure. |
| Please consult the CDC website for more travel information:
|
Example of a Pneumonic Plague Message Map
| Stakeholder:
Public | ||
|---|---|---|
| Key message 1 | Key message 2 | Key message 3 |
| Pneumonic plague is extremely difficult to contract person to person | Infection rate is extremely low | It is very difficult to spread pneumonic plague coast to coast |
| Supporting information 1–1 | Supporting information 2–1 | Supporting information 3–1 |
| 85% of pneumonic plague (also known as bubonic plague) cases are caused by transmission of the disease by rodents, and the disease does not spread easily from human to human | A person is only infectious for 1–3 days | The United States reports approximately 25 cases of pneumonic plague a year. There has not been a sustained outbreak for nearly a century. |
| Supporting information 1–2 | Supporting information 2–2 | Supporting information 3–2 |
| Pneumonic plague spread from person to person usually occurs after long periods of close contact, for example, in relation to caregivers or medical professionals | A person becomes ill very rapidly and it would be difficult to travel while experiencing symptoms | A disease with such a low infection rate cannot sustain a US-wide outbreak |
| Supporting information 1–3 | Supporting information 2–3 | Supporting information 3–3 |
| A person is not infectious without symptoms | A person suffering from pneumonic plague would be easier to spot than someone suffering from another disease due to the plague’s rapid progression and severity | Previous large numbers of pneumonic plague deaths were due to unsanitary conditions, lack of modern medicine and antibiotics, and large numbers of rodents |